CCL2 modulates cytokine production in cultured mouse astrocytes

Research output: Contribution to journalArticleResearchpeer-review

44 Citations (Scopus)

Abstract

The chemokine CCL2 (also known as monocyte chemoattractant protein-1, or MCP-1) is upregulated in patients and rodent models of traumatic brain injury (TBI), contributing to post-traumatic neuroinflammation and degeneration by directing the infiltration of blood-derived macrophages into the injured brain. Our laboratory has previously reported that Ccl2-/- mice show reduced macrophage accumulation and tissue damage, corresponding to improved motor recovery, following experimental TBI. Surprisingly, Ccl2-deficient mice also exhibited delayed but exacerbated secretion of key proinflammatory cytokines in the injured cortex. Thus we sought to further characterise CCL2 s potential ability to modulate immunoactivation of astrocytes in vitro.
Original languageEnglish
Pages (from-to)1 - 11
Number of pages11
JournalJournal of Neuroinflammation
Volume7
Issue number67
DOIs
Publication statusPublished - 2010

Cite this